Literature DB >> 22480900

Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Carlos Blanco1, Analucía A Alegría, Shang-Min Liu, Roberto Secades-Villa, Luisa Sugaya, Carrie Davies, Edward V Nunes.   

Abstract

OBJECTIVE: To investigate the association between substance use disorders (SUDs) and the clinical presentation, risk factors, and correlates of major depressive disorder (MDD) by examining differences among 3 groups: (1) individuals with lifetime MDD and no comorbid SUD (MDD-NSUD); (2) individuals with comorbid MDD and SUD (MDD-SUD); and (3) individuals with substance-induced depressive disorder (SIDD).
METHOD: Data were derived from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (N = 43,093). Diagnoses were made using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version.
RESULTS: The lifetime prevalence of MDD-NSUD was 7.41%, whereas those of MDD-SUD and SIDD were 5.82% and 0.26%, respectively. Overall, risk factors for MDD were more common among individuals with MDD-SUD and SIDD than among those with MDD-NSUD. Individuals with MDD-SUD and SIDD had similar rates of comorbidity with any psychiatric disorder, but both groups had higher rates than individuals with MDD-NSUD (odds ratio [OR] = 2.3; 95% CI, 1.9-2.7 and OR = 2.5; 95% CI, 1.4-4.4, respectively). Individuals with SIDD were significantly less likely to receive medication than those with MDD-SUD or MDD-NSUD (OR = 0.5; 95% CI, 0.3-0.9 for both groups).
CONCLUSIONS: MDD-SUD is associated with high overall vulnerability to additional psychopathology, a higher number of and more severe depressive episodes, and higher rates of suicide attempts in comparison to individuals with MDD-NSUD. SIDD has low prevalence in the general population but is associated with increased clinical severity and low rates of medication treatment. Similar patterns of comorbidity and risk factors in individuals with SIDD and those with MDD-SUD suggest that the 2 conditions may share underlying etiologic factors. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22480900     DOI: 10.4088/JCP.10m06673

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  28 in total

1.  Onset of Alcohol Use Disorders and Comorbid Psychiatric Disorders in a Military Cohort: Are there Critical Periods for Prevention of Alcohol Use Disorders?

Authors:  David S Fink; M Shayne Gallaway; Marijo B Tamburrino; Israel Liberzon; Philip Chan; Gregory H Cohen; Laura Sampson; Edwin Shirley; Toyomi Goto; Nicole D'Arcangelo; Thomas Fine; Philip L Reed; Joseph R Calabrese; Sandro Galea
Journal:  Prev Sci       Date:  2016-04

2.  Higher smoking prevalence among United States adults with co-occurring affective and drug use diagnoses.

Authors:  Maria A Parker; Stacey C Sigmon; Andrea C Villanti
Journal:  Addict Behav       Date:  2019-08-26       Impact factor: 3.913

3.  Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States.

Authors:  Mark Olfson; Melanie M Wall; Shang-Min Liu; Carlos Blanco
Journal:  Am J Psychiatry       Date:  2017-09-26       Impact factor: 18.112

4.  Correlates of depression in self-neglecting older adults: A cross-sectional study examining the role of alcohol abuse and pain in increasing vulnerability.

Authors:  Marissa C Hansen; David V Flores; John Coverdale; Jason Burnett
Journal:  J Elder Abuse Negl       Date:  2016

Review 5.  Impact of Sleep and Circadian Rhythms on Addiction Vulnerability in Adolescents.

Authors:  Ryan W Logan; Brant P Hasler; Erika E Forbes; Peter L Franzen; Mary M Torregrossa; Yanhua H Huang; Daniel J Buysse; Duncan B Clark; Colleen A McClung
Journal:  Biol Psychiatry       Date:  2017-12-15       Impact factor: 13.382

6.  Alcohol, Tobacco, and Comorbid Psychiatric Disorders and Associations With Sexual Identity and Stress-Related Correlates.

Authors:  Rebecca J Evans-Polce; Luisa Kcomt; Philip T Veliz; Carol J Boyd; Sean Esteban McCabe
Journal:  Am J Psychiatry       Date:  2020-09-11       Impact factor: 18.112

7.  Identifying a clinical signature of suicidality among patients with mood disorders: A pilot study using a machine learning approach.

Authors:  Ives Cavalcante Passos; Benson Mwangi; Bo Cao; Jane E Hamilton; Mon-Ju Wu; Xiang Yang Zhang; Giovana B Zunta-Soares; Joao Quevedo; Marcia Kauer-Sant'Anna; Flávio Kapczinski; Jair C Soares
Journal:  J Affect Disord       Date:  2016-01-01       Impact factor: 4.839

8.  Socio-environmental risks for untreated depression among formerly incarcerated Latino men.

Authors:  Miguel Muñoz-Laboy; Nancy Worthington; Ashley Perry; Vincent Guilamo-Ramos; Leopoldo Cabassa; Jane Lee; Nicolette Severson
Journal:  J Immigr Minor Health       Date:  2014-12

9.  Testing the drug substitution switching-addictions hypothesis. A prospective study in a nationally representative sample.

Authors:  Carlos Blanco; Mayumi Okuda; Shuai Wang; Shang-Min Liu; Mark Olfson
Journal:  JAMA Psychiatry       Date:  2014-11       Impact factor: 21.596

Review 10.  Medications for substance use disorders (SUD): emerging approaches.

Authors:  Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Expert Opin Emerg Drugs       Date:  2017-10-30       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.